Adi Mor
CEO
Immunology
Chemomab
Israel
Biography
ChemomAb is managed by Dr. Mor, who co-founded the company in 2011. Dr. Mor has extensive knowledge and experience in the fields of immunology, autoimmune and inflammatory diseases and a wide experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and cancer diseases. Dr. Mor completed her Ph.D. in Immunology from the Tel Aviv University in the Department of Neurobiochemistry and is a lead author of multiple publications in scientific journals in the fields of immunology and inflammatory disorders. ChemomAb is managed by Dr. Mor, who co-founded the company in 2011. Dr. Mor has extensive knowledge and experience in the fields of immunology, autoimmune and inflammatory diseases and a wide experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and cancer diseases. Dr. Mor completed her Ph.D. in Immunology from the Tel Aviv University in the Department of Neurobiochemistry and is a lead author of multiple publications in scientific journals in the fields of immunology and inflammatory disorders.
Research Interest
Immunology